Great find, also on Forbes now. With IHL-675A being a combination treatment consisting of hydroxychloroquine and cannabidiol, with the two components working synergistically, the potential for a unique drug for the prevention and treatment of Covid related inflammatory lung conditions looks very promising. Apart from the multi purpose efficacy for rheumatoid arthritis and inflammatory bowel disease.
- Forums
- ASX - By Stock
- IHL
- Ann: Update on Nasdaq Listing
Ann: Update on Nasdaq Listing, page-147
-
- There are more pages in this discussion • 605 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online